Lou Yuan Cheng - Net Worth and Insider Trading
Lou Yuan Cheng Net Worth
The estimated net worth of Lou Yuan Cheng is at least $23,963 dollars as of 2024-06-23. Lou Yuan Cheng is the Supervisors of Hualan Biological Vaccine Inc and owns about 1,350 shares of Hualan Biological Vaccine Inc (SZSE:301207) stock worth over $23,963. Details can be seen in Lou Yuan Cheng's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Lou Yuan Cheng has not made any transactions after 2022-07-14 and currently still holds the listed stock(s).
Transaction Summary of Lou Yuan Cheng
Lou Yuan Cheng Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lou Yuan Cheng owns 1 companies in total, including Hualan Biological Vaccine Inc (SZSE:301207) .
Click here to see the complete history of Lou Yuan Cheng’s form 4 insider trades.
Insider Ownership Summary of Lou Yuan Cheng
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SZSE:301207 | Hualan Biological Vaccine Inc | 2022-07-14 | Supervisors |
Lou Yuan Cheng Latest Holdings Summary
Lou Yuan Cheng currently owns a total of 1 stock. Lou Yuan Cheng owns 1,350 shares of Hualan Biological Vaccine Inc (SZSE:301207) as of July 14, 2022, with a value of $23,963.
Latest Holdings of Lou Yuan Cheng
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SZSE:301207 | Hualan Biological Vaccine Inc | 2022-07-14 | 1,350 | 17.75 | 23,963 |
Holding Weightings of Lou Yuan Cheng
Lou Yuan Cheng Form 4 Trading Tracker
According to the SEC Form 4 filings, Lou Yuan Cheng has made a total of 1 transactions in Hualan Biological Vaccine Inc (SZSE:301207) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Hualan Biological Vaccine Inc is the acquisition of 1,350 shares on July 14, 2022, which cost Lou Yuan Cheng around $48,717.
Insider Trading History of Lou Yuan Cheng
- 1
Lou Yuan Cheng Trading Performance
GuruFocus tracks the stock performance after each of Lou Yuan Cheng's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lou Yuan Cheng is -10.94%. GuruFocus also compares Lou Yuan Cheng's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lou Yuan Cheng within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Lou Yuan Cheng's insider trading performs compared to the benchmark.
Performance of Lou Yuan Cheng
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.07 | | | | | |
| Relative Return to S&P 500(%) | -12.85 | | | | | |
Lou Yuan Cheng Ownership Network
Lou Yuan Cheng Owned Company Details
What does Hualan Biological Vaccine Inc do?
Who are the key executives at Hualan Biological Vaccine Inc?
Lou Yuan Cheng is the Supervisors of Hualan Biological Vaccine Inc.
Hualan Biological Vaccine Inc (SZSE:301207) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Hualan Biological Vaccine Inc (SZSE:301207) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Hualan Biological Vaccine Inc (SZSE:301207) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Hualan Biological Vaccine Inc (SZSE:301207)'s detailed insider trading history can be found in Insider Trading Tracker table.
Hualan Biological Vaccine Inc Insider Transactions
Lou Yuan Cheng Mailing Address
Above is the net worth, insider trading, and ownership report for Lou Yuan Cheng. Currently GuruFocus does not have mailing address information for Lou Yuan Cheng.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
